Sign in to fuzzto save your conversations, follow your research and come back anytime.
Concord Biotech
SectorHealthcare
| Metric (₹ crore) | Q1 FY23 | Q2 FY23 | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 181 | 158.9 | 240.68 | 272.59 | 194.83 | 262.35 | 240.8 | 318.97 | 215.8 | 310.18 | 244.22 | 429.88 | 203.99 | 247.06 | 277.77 | 326.08 | 257.49 |
| Expenses | 116.37 | 121.46 | 130.71 | 145.54 | 122.68 | 146.63 | 134.87 | 186.88 | 134.52 | 176.46 | 146.27 | 241.01 | 142.59 | 158.57 | 179.48 | 207.73 | 175.11 |
| EBITDA | 64.63 | 37.44 | 109.97 | 127.05 | 72.15 | 115.72 | 105.93 | 132.09 | 81.28 | 133.72 | 97.95 | 188.87 | 61.4 | 88.49 | 98.29 | 118.35 | 82.38 |
| Depreciation | 13.57 | 12.51 | 13.77 | 14.18 | 13.04 | 13.3 | 13.54 | 13.72 | 13.18 | 13.31 | 13.26 | 14.62 | 17.78 | 18.39 | 18.75 | 19.54 | 18.1 |
| EBIT | 51.06 | 24.93 | 96.2 | 112.87 | 59.11 | 102.42 | 92.39 | 118.37 | 68.1 | 120.41 | 84.69 | 174.25 | 43.62 | 70.1 | 79.54 | 98.81 | 64.28 |
| Interest | 1.04 | 1.11 | 0.91 | 1.45 | 0.75 | 0.84 | 0.5 | 0.46 | 0.24 | 0.1 | 0.1 | 0.1 | 0.06 | 0.06 | 0.08 | 0.08 | 0.04 |
| Profit Before Tax | 50.02 | 23.82 | 95.29 | 111.42 | 58.36 | 101.58 | 91.89 | 117.91 | 67.86 | 120.31 | 84.59 | 174.15 | 43.56 | 70.04 | 79.46 | 98.73 | 64.24 |
| Net Profit | 49.26 | 21.97 | 77.37 | 91.49 | 54.49 | 81.02 | 77.57 | 95.02 | 59.59 | 95.74 | 75.92 | 140.39 | 44.06 | 63.06 | 63.64 | 88.47 | 57.7 |
| EPS | 4.71 | 2.1 | 7.4 | 8.75 | 5.21 | 7.74 | 7.41 | 9.08 | 5.7 | 9.15 | 7.26 | 13.42 | 4.21 | 6.03 | 6.08 | 8.46 | 5.52 |
| Metric (₹ crore) | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 155.09 | 166.81 | 207.47 | 246 | 265.47 | 244.52 | 266.88 |
| Investing Cash Flow | -113.93 | -195.44 | -111.79 | -157.95 | -154.61 | -159.99 | -142.72 |
| Financing Cash Flow | -42.52 | 31.37 | -100.16 | -85.22 | -99.21 | -98.77 | -112.88 |
| Net Cash Flow | -1.36 | 2.74 | -4.48 | 2.83 | 11.65 | -14.24 | 11.28 |
| Metric (₹ crore) | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| Equity / Shareholders' Funds | 770.23 | 999.37 | 1,103.22 | 1,290 | 1,526.65 | 1,812.72 | 2,015.14 |
| Total Liabilities | 170.49 | 183.17 | 209.57 | 223.98 | 174.06 | 221.53 | 219.59 |
| Total Assets | 940.73 | 1,182.54 | 1,312.79 | 1,513.98 | 1,700.71 | 2,034.25 | 2,234.73 |